NewslettersCell Therapy NewsPhenotypic Insights into Genetic Risk Factors for Immune-Related Adverse Events in Cancer ImmunotherapyBy Noshin Noorjahan - November 4, 202401346Utilizing publicly accessible genome-wide association study data, this investigation evaluated the impact of over 5000 exposure variables on susceptibility to irAEs using univariate Mendelian randomization.[Cancer Immunology Immunotherapy]Full Article